Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	14.96	25.47	22.16
Graham Fair Price	147.74	5601.32	2260.96
PEG	-98.15	-0.02	1.02
Price/Book	-11.72	0.44	0.50
Price/Cash Flow	273.82	-106.47	28.48
Prices/Earnings	-84.99	13.27	-88.37
Price/Sales	-0.28	2.43	2.44
Price/FCF	273.82	-106.47	28.48
Naive Interpretation	member

01 - Valuation · Somewhat Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	4.79	0.60	0.58
Operating Margin	-17.83	0.07	0.09
ROA	491.61	< 0.005	< 0.005
ROE	< 0.005	< 0.005	488.00
ROIC	0.02	< 0.005	-56.94
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.02	-0.26	-93.36
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	4.41	-0.25	-94.34
EPS QOQ	0.87	7.01	709.60
FCF QOQ	5.32	-1.24	-76.64
Revenue QOQ	0.13	-0.09	-33.84
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	94.76	115.76	22.16
Days Sales Outstanding (DSO)	70.42	80.86	14.82
Inventory Turnover	0.95	0.78	-18.14
Debt/Capitalization	0.14	0.14	-2.26
Quick Ratio	1.17	1.19	1.86
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	12706.81	12982.09	2.17
Cash	2084.42	2007.72	-3.68
Capex	-20.79	-41.06	-97.48
Free Cash Flow	221.90	-53.54	-75.87
Revenue	2591.17	2343.64	-9.55
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.51	1.56	3.65
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	0.20	0.66	221.43
Naive Interpretation	Member

06 - Financial Health · Weak

Rating